Clinical Trial Update: A Switch Study From High-Sodium Oxybate to Xywav to Evaluate Changes in Blood Pressure in Participants With Narcolepsy [Phase 4]

View source ↗

Summary

Phase 4 switch study evaluated blood pressure changes when narcolepsy patients moved from high-sodium oxybate (Xyrem) to Xywav, with results posted on 2026-04-2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy

Drugs mentioned

• XYWAV (CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES)
• Xyrem (Sodium Oxybate)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Narcolepsy | Phase 4 | Status: COMPLETED | Results posted: 2026-04-24